France | IENT

ANR BMAALS

ANR BMAALS

Première étude en France du lien possible entre Sclérose Latérale Amyotrophique et la cyanotoxine BMAA L’objectif principal de ce projet est d’améliorer significativement les connaissances scientifiques sur le lien possible entre la Sclérose Latérale...

Plus d'info

Delzor et al. (2014) – Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme

Delzor et al. (2014) – Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme

Delzor A., Couratier P., Boumédiène F., Nicol M., Druet-Cabanac M., Paraf F., Méjean A., Ploux O., Leleu J.P., Brient L., Lengronne M., Pichon V., Combès A., El Abdellaoui S., Bonneterre V., Lagrange E., Besson G., Bicout D.J., Boutonnat J., Camu W., Pageot N.,...

Plus d'info

Marin et al. (2014) – Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe – the French register of ALS in Limousin (FRALim register)

Marin et al. (2014) – Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe – the French register of ALS in Limousin (FRALim register)

Marin B., Hamidou B., Couratier P., Nicol M., Delzor A., Raymondeau M., Druet-Cabanac M., Lautrette G., Boumediene F., Preux P.M.; French register of ALS in Limousin (FRALim) Eur J Neurol. 2014 Oct;21(10):1292-e79 –  Epub 2014 Jun 9 – Accès réservé BACKGROUND...

Plus d'info

Combès et al. (2014) – Development of an analytical procedure for quantifying the underivatized neurotoxin β-N-methylamino-L-alanine in brain tissues

Combès et al. (2014) – Development of an analytical procedure for quantifying the underivatized neurotoxin β-N-methylamino-L-alanine in brain tissues

Combes A., El Abdellaoui S., Vial J., Lagrange E., Pichon V., BMAALS group Anal Bioanal Chem. 2014 Jul;406(19):4627-36 – Epub 2014 May 25 – Accès réservé The cyanotoxin β-methylamino-L-alanine (BMAA) has received renewed attention as an environmental risk...

Plus d'info

Thèse soutenue de Bello HAMIDOU

Thèse soutenue de Bello HAMIDOU

Epidémiologie de la Sclérose Latérale Amyotrophique La sclérose Latérale Amyotrophique (SLA) est une maladie neuro-dégénérative rare. Il n’existe aucune donnée d’incidence française en population générale. Le profil phénotypique des patients...

Plus d'info

Masseret et al. (2013) – Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from southern France

Masseret et al. (2013) – Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from southern France

Masseret E., Banack S., Boumédiène F., Abadie E., Brient L., Pernet F., Juntas-Morales R., Pageot N., Metcalf J., Cox P., Camu W. PLoS ONE 8, 12 (2013) e83406 – Epub 2013 Dec 13 – Accès réservé PURPOSE: Dietary exposure to the cyanotoxin BMAA is suspected to...

Plus d'info

Delzor et al. (2013) – BMAALS: A French national project searching for a link between amyotrophic lateral sclerosis and the neurotoxic amino acid L-BMAA

Delzor et al. (2013) – BMAALS: A French national project searching for a link between amyotrophic lateral sclerosis and the neurotoxic amino acid L-BMAA

Delzor A., Marin B., Boumediene F., Preux P.-M., Couratier P., Group BMAALS Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):155-6 – Epub 2013 Oct 8 – Accès réservé No abstract...

Plus d'info

Combès et al. (2013) – Validation of the analytical procedure for the determination of the neurotoxin β-N-methylamino-L-alanine in complex environmental samples

Combès et al. (2013) – Validation of the analytical procedure for the determination of the neurotoxin β-N-methylamino-L-alanine in complex environmental samples

Combes A., El Abdellaoui S., Sarazin C., Vial J., Mejean A., Ploux O., Pichon V., Group BMAALS Analytica Chimica Acta 771 (2013) 42-9 – Epub 2013 Feb 19 – Accès réservé The neurotoxic l-2-amino-3-methylaminopropionic acid (BMAA) was hypothesized to be involved...

Plus d'info

Jesus et al. (2012) – First assessment at home of amyotrophic lateral sclerosis (ALS) patients by a nutrition network in the French region of Limousin

Jesus et al. (2012) – First assessment at home of amyotrophic lateral sclerosis (ALS) patients by a nutrition network in the French region of Limousin

Jesus P., Massoulard A., Marin B., Nicol M., Laplagne O., Baptiste A., Gindre-Poulvelarie L., Couratier P., Fraysse J.L., Desport J.C. Amyotroph Lateral Scler. 2012 Oct;13(6):538-43 – Epub 2012 Jul – Accès réservé ABSTRACT: Malnutrition is associated with poor...

Plus d'info

Boumédiène et al. (2011) – Contribution of geolocalisation to neuroepidemiological studies: incidence of ALS and environmental factors in Limousin, France

Boumédiène et al. (2011) – Contribution of geolocalisation to neuroepidemiological studies: incidence of ALS and environmental factors in Limousin, France

Boumédiène F., Druet-Cabanac M., Marin B., Preux P.-M., Allee P., Couratier P. Journal of the Neurological Sciences 309, 1-2 (2011) 115-22 – Epub 2011 Aug 3 – Accès réservé This article aimed to detect clusters of amyotrophic lateral sclerosis (ALS) and...

Plus d'info

Gil et al. (2009) – Prognosis of ALS: comparing data from the Limousin referral centre, France, and a Uruguayan population

Gil et al. (2009) – Prognosis of ALS: comparing data from the Limousin referral centre, France, and a Uruguayan population

Gil J., Vazquez M.C., Ketzoian C., Perna A., Marin B., Preux P.M., Couratier P. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):355-60 – Epub Oct 2009 – Accès réservé ABSTRACT: Our objective was to compare clinical features and survival in two groups of ALS...

Plus d'info

Marin et al. (2009) – Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997-2007

Marin et al. (2009) – Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997-2007

Marin B.., Gil J., Preux P.M., Funalot B., Couratier P. Amyotroph Lateral Scler. 2009 Aug;10(4):216-20 – Epub 2009 Aug –  Accès réservé ABSTRACT: Our objective was to assess the incidence of amyotrophic lateral sclerosis (ALS), and its temporal variations,...

Plus d'info
© UMR Inserm 1094 NET - 2 rue du Dr Marcland, 87025 LIMOGES Cedex - Tél. : 05 55 43 58 20 - Fax : 05 55 43 58 21